Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

EU Extends Review of Teva, Cephalon Deal After Remedies

The European Commission extended its review of Teva Pharmaceutical Industries Ltd.’s bid for Cephalon Inc. after it was offered remedies to allay possible competition concerns over the deal.

The new deadline is Oct. 13, the commission said in a filing on its website today. It didn’t specify the remedies that were offered.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.